MHRA Appoints New Chief Executive
News Jul 05, 2013
He will take up the post in September when current Chief Executive Sir Kent Woods steps down, after ten years with the agency.
Dr Hudson is currently the MHRA’s Licensing Director, responsible for the majority of medicines licensing activities. He is the UK delegate to the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency and has been its vice-chairman since October 2012.
In line with Government protocol, the Department of Health officially announced the appointment and their press release is available through the link below.
RELATED ARTICLES
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until Now
NewsA new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.
READ MORE
Sekisui XenoTech Appoints New COO
NewsCompany hires CRO & pharma veteran, Dr. Darren Warren, as new Chief Operating Officer.
READ MORE
Researchers Reveal How Superbug Secretes It’s Toxin
NewsMonash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.